Amer El Ghali (Amer El-Ghali)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Cardiovascular Events

Pseudomonas Aeruginosa

Acinetobacter Baumannii

Top Venues

Microbiology spectrum

Open forum infectious diseases

Antimicrobial agents and chemotherapy

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, Molly Tieman, Xhilda Xhemali, Suet-Ping Lau, Gabriela Iturralde, Andrew Purdy, Dana J Holger, Esther Garcia, Michael P Veve, Michael Joseph Rybak
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology spectrum 12 (2) (2024)
Amer El Ghali, Ashlan J Kunz Coyne, Kaylee E Caniff, Callan Bleick, Michael Joseph Rybak
Sulbactam-durlobactam: A Novel β-lactam-β-lactamase Inhibitor Combination Targeting Carbapenem-Resistant Acinetobacter baumannii Infections. Pharmacotherapy (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Amer El Ghali, Taylor Morrisette, Sara Alosaimy, Kristen Lucas, Maria G Tupayachi-Ortiz, Raaga Vemula, Carly Wadle, Julie V Philley, Carlos Mejia-Chew, Yasir Hamad, Ryan W Stevens, John D Zeuli, Andrew J Webb, Christina T Fiske, Anahit Simonyan, Christo L Cimino, Mehriban Mammadova, Virginia E Umana, Rodrigo Hasbun, Saira Butt, Kyle C Molina, Michael Thomas, Emily A Kaip, Jeannette Bouchard, Tristan W Gore, Catessa Howard, M Gabriela Cabanilla, Dana J Holger, Jeremy J Frens, Melissa Barger, Aaron Ong, Keira A Cohen, Michael Joseph Rybak
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes. Antimicrobial agents and chemotherapy (2023)
Amer El Ghali, Kyle Stamper, Ashlan J Kunz Coyne, Dana J Holger, Razieh Kebriaei, Jose Alexander, Susan M Lehman, Michael Joseph Rybak
Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models. Antimicrobial agents and chemotherapy (2023)
Ashlan J Kunz Coyne, Kyle Stamper, Amer El Ghali, Razieh Kebriaei, Biswajit Biswas, Melanie Wilson, Michael V Deschenes, Truc T Tran, César A Arias, Michael Joseph Rybak
Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model. Microbiology spectrum (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Dana J Holger, Nicholas Rebold, Michael J Rybak
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious diseases and therapy 11 (2) (2022)